Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease

Abstract

Furthermore, socioeconomic factors, demographic factors, and health status, which play a critical role in drug cost affordability, were not included in this analysis and warrant further evaluation.

Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021

“…1,2 Delays in generic competition have reduced patient access and led to unnecessary health care spending. 2,3 To better understand the financial value of patents to inhaler manufacturers, we quantified the revenue earned on all brand-name prescription inhalers approved by the US Food and Drug Administration (FDA) from 2000 to 2021 and compared earnings before and after expiration of primary patents on these products.…”